StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > We need a large US based marketing firm!!!

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Feb 15, 2021 6:14pm

148 Views

Post# 32569777

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:We need a large US based marketing firm!!!

I would expect they have a plan. They indicated in the prospectus up to $3 million for the roll out at maximum so at 75% should be close to $2 million. With additional convid revenue could be more.

let's see what $2-3 million in marketing gets yah

come on Tripp show us how you launch a product 15 years in the making